Core E: Outreach, Recruitment & Education
核心 E:外展、招聘
基本信息
- 批准号:9256419
- 负责人:
- 金额:$ 11.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAmberAmyloidAutopsyAwarenessBasic ScienceBiological MarkersBrainCaliforniaCellsChinese AmericanClinicalClinical DataClinical ResearchClinical SciencesClinical TrialsCollaborationsCommunicationCommunitiesCommunity HealthCommunity HealthcareCountyCustomDataData CollectionDementiaDiagnosisDown SyndromeEducationEducation and OutreachEducational MaterialsEffectivenessEnrollmentEventFacultyFamily CaregiverFosteringFutureGoalsGrantHealth ProfessionalIndividualLatinoLinkLongitudinal cohortMinorityMinority GroupsMinority RecruitmentMissionMonitorNewsletterOrangesParticipantPhysiciansPrevention trialRecruitment ActivityRegistriesResearchResearch PersonnelResourcesStrategic PlanningStudentsSystemTrainingTraining and EducationUniversitiesWorkcohesioncohortcommunity organizationscommunity partnershipdemographicsdigitaldisease diagnosisdisease registryimprovedinduced pluripotent stem cellinnovationmeetingsneuropathologyoutreachpre-clinicalpreventprogramsscience teacherskillssuccesssymposiumweb site
项目摘要
Core E: Outreach, Recruitment & Education Core
Project Summary/Abstract
The Outreach, Recruitment and Education (ORE) Core has two primary goals that drive the aims of the
core and its strategy for implementing successful programs. The primary goal is to recruit and retain
research participants that meet the requirements of the ADRC cohorts, the projects and pilots of the
ADRC, and clinical studies and trials. The ORE Core will support recruitment and retention in all ADRC
cohorts (longitudinal, Down syndrome, and 90+ Autopsy Study) through innovative and customized
public events, physician outreach, newsletters, digital communications, and retention/appreciation
events. In addition, the ORE Core will expand recruitment efforts to support the newly established iPS
Cell Core and the proposed AmBER registry Amyloid Biomarker Enrichment Registry (see Clinical
Core.) Biweekly meetings are held between the ORE and Clinical Cores to set recruitment goals and
monitor progress. The ORE Core will build on the successes of the past grant cycle by honing data
collection and tracking systems to improve recruitment efforts, such as targeting physicians for
additional referrals to the ADRC, and maximizing traffic on the ADRC website to convert visitors to
participants. Minority recruitment will continue to be a focus of the ORE Core, and we will engage our
community partners, local referring physicians, and our current minority participants to help us double
current Chinese-American enrollment into the longitudinal cohort, to a goal of 30%. In addition, the
Down Syndrome cohort will increase Latino enrollment, to a goal of 21%, reflecting our community
demographics. Our secondary goal is the education and training of scientific investigators and
clinicians and the programmatic education of Orange County's lay and professional community about
AD, the mission of the UCI ADRC, and the importance and impact of research. We will develop and
coordinate educational programs for UCI students, staff, and faculty to enhance collaboration and
education. We will continue our annual Southern California Alzheimer s Disease Research
Conference, now in our 25th year, participate in the annual ADC symposium with the other local ADCs,
and develop a new speakers bureau. Finally, the ORE Core recognizes the importance of
centeredness and will continue to develop cross-core collaborations that are cohesive to the overall
objectives of the UCI ADRC and advance the specific aims of each core.
核心E:外联、招聘和教育核心
项目总结/摘要
外联、招聘和教育(ORE)核心有两个主要目标,这两个目标推动了
其核心和战略,以实施成功的方案。首要目标是招募和留住
符合ADRC队列要求的研究参与者,
ADRC,临床研究和试验。ORE核心将支持所有ADRC的招聘和保留
队列(纵向,唐氏综合征和90+尸检研究),通过创新和定制
公共活动、医生外展、通讯、数字通信和保留/赞赏
事件此外,ORE Core还将扩大招聘力度,以支持新成立的iPS
Cell Core和AmBER登记处淀粉样蛋白生物标志物富集登记处(见临床
核心。)ORE和临床核心之间每两周举行一次会议,以设定招募目标,
监测进展情况。ORE核心将通过磨练数据,在过去资助周期成功的基础上再接再厉
收集和跟踪系统,以改善招聘工作,如针对医生,
更多的转介到ADRC,并最大限度地提高ADRC网站的流量,以将访问者转化为
参与者少数族裔招聘将继续是ORE核心的重点,我们将参与我们的
社区合作伙伴,当地的转诊医生,以及我们目前的少数参与者,帮助我们加倍
目前的华裔美国人进入纵向队列,目标是30%。此外该
唐氏综合症队列将增加拉丁裔入学率,达到21%的目标,反映我们的社区
人口统计学我们的第二个目标是教育和培训科学研究人员,
临床医生和橙子县的外行和专业社区的计划教育,
AD,UCI ADRC的使命,以及研究的重要性和影响。创新和
协调UCI学生,员工和教师的教育计划,以加强合作,
教育我们将继续我们的年度南加州阿尔茨海默病研究
会议,现在在我们的第25个年头,参加每年的ADC研讨会与其他地方ADC,
建立一个新的发言人办公室最后,ORE核心认识到以下重要性:
中心化,并将继续发展跨核心协作,与整体
UCI ADRC的目标,并推进每个核心的具体目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Aimee Pierce其他文献
Aimee Pierce的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Aimee Pierce', 18)}}的其他基金
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 11.82万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 11.82万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 11.82万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 11.82万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 11.82万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 11.82万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 11.82万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 11.82万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 11.82万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 11.82万 - 项目类别: